Clinical Trials Directory

Trials / Unknown

UnknownNCT05657132

Antibacterial Effect of New Herbal Paste Used as an Intracanal Medication

Antibacterial Effect of New Herbal Paste Used as an Intracanal Medication in Necrotic Primary Molars, a Randomized Control Trial

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Nahda University · Academic / Other
Sex
All
Age
4 Years – 10 Years
Healthy volunteers
Accepted

Summary

studying the antibacterial effect of Cosuts paste as an intracanal medication against Enterococcus faecalis that present in necrotic primary teeth

Detailed description

The children were randomly divided into two groups (I, II) Group I (N=12): using Costus-based paste as an intracanal medicament. Group II (N= 12): Calcium hydroxide iodoform paste (Metapex) as an intracanal medicament. Procedure: Access opening was started. then a swab was taken from the distal root canal with a dry paper point and transferred to a sterile test tube. The canals were filled with an intracanal medication according to the patient group. In group I, the canals was filled with a previously prepared Costus-based paste for one week, and In Group II, the canals were filled with Meta paste for one week. After 1 week, the paste was washed away from the canals then another swab was taken from the distal canal by a dry paper point as done before preoperatively. The 2 swabs were transferred within 2 hours to the lab for bacterial culture and detection of enterococcus faecalis count.

Conditions

Interventions

TypeNameDescription
DRUGherbal intracanal medication pastestudy the effect of costus herbal paste on enterococcus faecalis bacteria
DRUGMeta pastecompare the effect of Costus paste with meta paste in reducing the number of enterococcus faecalis

Timeline

Start date
2021-08-19
Primary completion
2022-12-10
Completion
2022-12-30
First posted
2022-12-20
Last updated
2022-12-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05657132. Inclusion in this directory is not an endorsement.